Ipsen Biopharm Ltd. is seeking an Early Development Asset Lead to drive integrated development strategy and execution for one or more early-stage assets from nomination through first-in-human trials.
The role leads the Early Development Asset Team, coordinating clinical, regulatory, CMC, translational, pharmacology, and safety inputs to advance programs with scientific rigor and portfolio alignment.
#J-18808-Ljbffr
Full job description from WhatJobs. Apply for this role →
Wrexham, Clwyd
Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease…
London
BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions.
London
Relation is a sector defining TechBio company developing transformational medicines, with technology at our core.
Explore: Specialist jobs in London
Worked with Verifera as a candidate or employer? Your honest review helps the next person trust verified hiring.